Travere Therapeutics, Inc.

Q3 2026 13F Holders

Symbol
TVTX
CUSIP
89422G107
Type
Equity
Class
COM
Num filings
8
Total reported value, excl. options
$6.08 M
Manager Report Date Value ($000) Shares Option Type